Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleEVIDENCE-BASED CLINICAL MEDICINE

Interpreting COVID-19 Test Results in Clinical Settings: It Depends!

Rachael Piltch-Loeb, Kyeong Yun Jeong, Kenneth W. Lin, John Kraemer and Michael A. Stoto
The Journal of the American Board of Family Medicine February 2021, 34 (Supplement) S233-S243; DOI: https://doi.org/10.3122/jabfm.2021.S1.200413
Rachael Piltch-Loeb
From the Harvard T.H. Chan School of Public Health, Emergency Preparedness Research Evaluation Program, Boston MA (RP-L); Georgetown University School of Medicine (KYJ); Georgetown University Medical Center, Department of Family Medicine (KWL); Georgetown University, Department of Health Systems Administration, Washington DC (JK, MAS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyeong Yun Jeong
From the Harvard T.H. Chan School of Public Health, Emergency Preparedness Research Evaluation Program, Boston MA (RP-L); Georgetown University School of Medicine (KYJ); Georgetown University Medical Center, Department of Family Medicine (KWL); Georgetown University, Department of Health Systems Administration, Washington DC (JK, MAS).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth W. Lin
From the Harvard T.H. Chan School of Public Health, Emergency Preparedness Research Evaluation Program, Boston MA (RP-L); Georgetown University School of Medicine (KYJ); Georgetown University Medical Center, Department of Family Medicine (KWL); Georgetown University, Department of Health Systems Administration, Washington DC (JK, MAS).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Kraemer
From the Harvard T.H. Chan School of Public Health, Emergency Preparedness Research Evaluation Program, Boston MA (RP-L); Georgetown University School of Medicine (KYJ); Georgetown University Medical Center, Department of Family Medicine (KWL); Georgetown University, Department of Health Systems Administration, Washington DC (JK, MAS).
JD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Stoto
From the Harvard T.H. Chan School of Public Health, Emergency Preparedness Research Evaluation Program, Boston MA (RP-L); Georgetown University School of Medicine (KYJ); Georgetown University Medical Center, Department of Family Medicine (KWL); Georgetown University, Department of Health Systems Administration, Washington DC (JK, MAS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Kim VS
    . Korea’s rapid testing, far ahead of the US, could be saving lives. Los Angeles Times. March 14, 2020.
  2. 2.↵
    1. Shear M,
    2. Goodnough A,
    3. Kaplan S,
    4. Fink S,
    5. Thomas K,
    6. Weiland N
    . The lost month: how a failure to test blinded the US to COVID-19. The New York Times. March 28, 2020.
  3. 3.↵
    1. McCoy K
    . ‘Vital and urgent’: New York City’s difficult quest to obtain coronavirus testing kits. USA Today. March 21, 2020.
  4. 4.↵
    1. Lazar K,
    2. Moore D
    . Testing delays are hurting the effort to contain COVID-19. The Boston Globe. July 21, 2020.
  5. 5.↵
    1. Ulrich A,
    2. Bartkus J,
    3. Moore K,
    4. Hansen G,
    5. Mathieson M,
    6. Osterholm M
    . COVID-19: The CIDRAP Viewpoint. University of Minnesota. May 20, 2020.
  6. 6.↵
    1. Liang H,
    2. Acharya G
    . Novel corona virus disease (COVID‐19) in pregnancy: what clinical recommendations to follow? Acta Obstet Gynecol Scand 2020;99:439–42.
    OpenUrlPubMed
  7. 7.↵
    1. Adams JG,
    2. Walls RM
    . Supporting the health care workforce during the COVID-19 global epidemic. JAMA 2020;323:1439–40.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Glanz K,
    2. Rimer B,
    3. Viswanath K
    1. Champion VL,
    2. Skinner CS
    . The health belief model. In: Glanz K, Rimer B, Viswanath K, editors. Health behavior and health education: Theory, research, and practice, 4th edition. San Francisco: Jossey-Bass; 2008. p. 45–65.
  9. 9.↵
    1. Wagner PJ,
    2. Curran P
    . Health beliefs and physician identified “worried well”. Health Psychol 1984;3:459–74.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Lynn M
    . Scarcity effects on value: a quantitative review of the commodity theory literature. Psychol Mark 1991;8:43–57.
    OpenUrl
  11. 11.↵
    1. Phelan AL
    . COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges. Lancet 2020;395:1595–8.
    OpenUrlCrossRefPubMed
  12. 12.
    1. Weise KW
    . ‘Way too late’: inside Amazon’s biggest outbreak. The New York Times. May 19, 2020.
  13. 13.↵
    1. Paltiel D,
    2. Zheng A,
    3. Rochelle P,
    4. et al
    . Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States. JAMA Netw Open 2020;3:e2016818.
  14. 14.↵
    1. Alter G,
    2. Seder R
    . The power of antibody-based surveillance. N Engl J Med 2020;383:1782–84.
    OpenUrlPubMed
  15. 15.↵
    1. Gottlieb S,
    2. McClellan M,
    3. Silvis L,
    4. et al
    . National coronavirus response: A road map to reopening. American Enterprise Institute. March 29, 2020.
  16. 16.↵
    Center for Disease Control and Prevention. COVID View: A weekly surveillance summary of US COVID-19 activity. Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html. Accessed July 24, 2020.
  17. 17.↵
    1. Paul K
    . Apple and Google release phone technology to notify users of coronavirus exposure. The Guardian. May 20, 2020.
  18. 18.↵
    1. Mervosh S,
    2. Fernandez M
    . Months into virus crisis, still lack testing capacity. The New York Times. July 15, 2020.
  19. 19.↵
    US Food and Drug Administration. Emergency Use Authorizations. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed July 29, 2020.
  20. 20.↵
    1. Lin KW,
    2. Kraemer JD,
    3. Piltch-Loeb R,
    4. Stoto MA
    . The complex interpretation and management of zika virus test results. J Am Board Fam Med 2018;31:924–30.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Irfan U
    . Why even a super-accurate Covid-19 test can fail. Vox May 27, 2020.
  22. 22.↵
    1. Haugh T,
    2. Bedi S
    . Just because you test positive for antibodies doesn’t mean you have them. The New York Times. May 13, 2020.
  23. 23.↵
    US Food and Drug Administration. Emergency Use Authorizations. Approval letter to manufacturer. Available at: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed May 8, 2020.
  24. 24.↵
    Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): Using Antigen Tests. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html. Accessed September 4, 2020.
  25. 25.↵
    1. Paltiel D,
    2. Walensky R
    . Screening to prevent SARS-CoV-2 outbreaks: saliva-based antigen testing is better than the PCR swab. Health Affairs. September 11, 2020.
  26. 26.↵
    1. Yang Y,
    2. Yang M,
    3. Shen C,
    4. et al
    . Laboratory diagnosis and monitoring the viral shedding of SARS CoV-2 infection. The Innovation 2020;1(3):100061.
    OpenUrl
  27. 27.↵
    Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): Duration of Isolation & Precautions for Adults. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html. Accessed September 10, 2020.
  28. 28.↵
    1. Cox R,
    2. Brokstad K
    . Not just antibodies: B cells and T cells mediate immunity to COVID-19. Nature Rev Immunol 2020;20:581–2.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Mervosh S,
    2. Fernandez M
    . ‘It’s like having no testing’: coronavirus test results are still delayed. The New York Times. August 4, 2020.
  30. 30.↵
    Government of the District of Columbia. District of Columbia COVID-19 Testing Sites. 2020. Available at: https://coronavirus.dc.gov/testing. Accessed July 24, 2020.
  31. 31.↵
    1. Nalla A,
    2. Casto A,
    3. Huang M,
    4. et al
    . A comparative performance of SARS-CoV-2 detection assays using seven different primer/probe sets and one assay kit. J. Clin. Microbiol 2020;58:e00557-20.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    FIND. SARS-CoV-2 diagnostics: performance data. March 27, 2020. Available at: https://www.finddx.org/covid-19/dx-data/. Accessed July 24, 2020.
  33. 33.↵
    1. Kim H,
    2. Hong H,
    3. Yoon S
    . Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology 2020;296:E145–E155.
    OpenUrlPubMed
  34. 34.↵
    1. Xiao A,
    2. Tong Y,
    3. Zhang S
    . False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence [published online ahead of print, 2020 Apr 9]. J Med Virol 2020;92:1755–6.
    OpenUrlPubMed
  35. 35.↵
    1. Corman V,
    2. Olfert L,
    3. Kaiser M,
    4. et al
    . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020;25:2000045.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Mousavizadeh L,
    2. Sorayya G
    . Genotype and phenotype of COVID-19: their roles in pathogenesis [published online ahead of print, 2020 Mar 31]. J Microbiol Immunol Infect 2020.
  37. 37.↵
    1. Long Q,
    2. Tang X,
    3. Shi Q,
    4. et al
    . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections [published online ahead of print, 2020 Jun 18]. Nat Med 2020;26:1200–4.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Kirkcaldy RD,
    2. King BA,
    3. Brooks JT
    . COVID-19 and postinfection immunity: limited evidence, many remaining questions. JAMA 2020;323:2245–6.
    OpenUrlPubMed
  39. 39.↵
    1. Zhao J,
    2. Yuan Q,
    3. Wang H,
    4. et al
    . Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020:ciaa344.
  40. 40.↵
    1. Wolfel R,
    2. Corman V,
    3. Guggemos W,
    4. et al
    . Virological assessment of hospitalized patients with COVID-19. Nature 2020;581:465–9.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Kojima N,
    2. Turner F,
    3. Slepnev V,
    4. et al
    . Self-collected oral fluid and nasal swabs demonstrate comparable sensitivity to clinician collected nasopharyngeal swabs for Covid-19 detection. Preprint. MedRxiv 2020.
  42. 42.↵
    1. Teo A,
    2. Choudhury Y,
    3. Tan L,
    4. et al
    . Validation of saliva and self-administered nasal swabs for COVID-19 testing. Preprint. MedRxiv 2020.
  43. 43.↵
    1. Seaman C,
    2. Tran L,
    3. Cowling B,
    4. et al
    . Self-collected compared with professional-collected swabbing in the diagnosis of influenza in symptomatic individuals: a meta-analysis and assessment of validity. J Clin Virol 2019;118:28–35.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Castro R,
    2. Paula LM,
    3. Mayumi WD,
    4. et al
    . COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil. Braz J Infect Dis 2020;24:180–7.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Whitman JD,
    2. Hiatt J,
    3. Mowery CT,
    4. et al
    . Test performance evaluation of SARS-CoV-2 serological assays. Preprint. MedRxiv 2020.
  46. 46.↵
    1. Cassaniti I,
    2. Novazzi F,
    3. Giardina F
    , Members of the San Matteo Pavia COVID‐19 Task Forceet al. Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department [published online ahead of print, 2020 Mar. J Med Virol 2020;92:1724–7.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Wan WY,
    2. Lim SH,
    3. Seng EH
    . Cross-reaction of sera from COVID-19 patients with SARS-CoV assays. Preprint. MedRxiv 2020.
  48. 48.↵
    Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): Interim Guidelines for COVID-19 Antibody Testing. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html. Accessed September 1, 2020.
  49. 49.↵
    Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19): Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html. Accessed July 20, 2020.
  50. 50.↵
    1. Wu KJ
    . A new generation of fast coronavirus tests is coming. The New York Times. July 6, 2020.
  51. 51.↵
    1. Moore D,
    2. Arnett D,
    3. Annear S
    . Delays. confusion. just how hard is it to line up a COVID-19 test? The Boston Globe. July 24, 2020.
  52. 52.↵
    1. Rosenthal E
    . When is a coronavirus test not a coronavirus test? The New York Times. July 24, 2020.
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family  Medicine: 34 (Supplement)
The Journal of the American Board of Family Medicine
Vol. 34, Issue Supplement
February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interpreting COVID-19 Test Results in Clinical Settings: It Depends!
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Interpreting COVID-19 Test Results in Clinical Settings: It Depends!
Rachael Piltch-Loeb, Kyeong Yun Jeong, Kenneth W. Lin, John Kraemer, Michael A. Stoto
The Journal of the American Board of Family Medicine Feb 2021, 34 (Supplement) S233-S243; DOI: 10.3122/jabfm.2021.S1.200413

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Interpreting COVID-19 Test Results in Clinical Settings: It Depends!
Rachael Piltch-Loeb, Kyeong Yun Jeong, Kenneth W. Lin, John Kraemer, Michael A. Stoto
The Journal of the American Board of Family Medicine Feb 2021, 34 (Supplement) S233-S243; DOI: 10.3122/jabfm.2021.S1.200413
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • The Who, Why, and How of COVID-19 Testing
    • What Types of Tests Exist?
    • Considerations for Advising Patients
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Primary Care in the COVID-19 Pandemic: Essential, and Inspiring
  • Google Scholar

More in this TOC Section

  • Practical Recommendations for Minimizing Pain and Anxiety with IUD Insertion
  • A Simplified Approach to Evaluate and Manage Shoulder Pain
  • Treatment of Vasomotor Symptoms
Show more Evidence-Based Clinical Medicine

Similar Articles

Keywords

  • Clinical Decision-Making
  • Contact Tracing
  • COVID-19
  • Evidence-Based Medicine
  • Population Health
  • Probability
  • Public Health
  • Sensitivity and Specificity

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire